Entering text into the input field will update the search result below

CRISPR Therapeutics hires Chief Medical Officer

May 17, 2022 8:15 AM ETCRISPR Therapeutics AG (CRSP) StockBy: Preeti Singh, SA News Editor
  • Phuong Khanh Morrow has been appointed as Chief Medical Officer at biopharmaceutical company CRISPR Therapeutics (NASDAQ:CRSP).
  • Morrow assumes the role on May 23, 2022 and will oversee the firm's global clinical development and regulatory operations.
  • She holds over a decade of leadership experience in global drug development, having served as VP and Global Therapeutic Area Head of Hematology, GI Oncology, GU Oncology, and Bone at Amgen (AMGN) most recently.
 

Recommended For You

More Trending News

About CRSP Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CRSP--
CRISPR Therapeutics AG